Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pregnancy and neonatal outcomes in Eastern Democratic Republic of the Congo: a systematic review.
Kasonia K, Brindle H, Manno D, Edwards T, Gardais S, Mambula G, Mossoko Z, Choi EM, Connor NE, Mukadi P, Grais RF, Keshinro B, Roberts CH, Kavunga-Membo H, Bausch DG, Muyembe JJ, Watson-Jones D. Kasonia K, et al. Among authors: roberts ch. Front Glob Womens Health. 2024 Dec 5;5:1412403. doi: 10.3389/fgwh.2024.1412403. eCollection 2024. Front Glob Womens Health. 2024. PMID: 39703717 Free PMC article.
Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination.
Muyembe JJ, Pan H, Peto R, Diallo A, Touré A, Mbala-Kingebene P, Bateyi Mustafa SH, Tambwe N, Mulangu S, Ahuka-Mundeke S, Mukamba Musenga E, Enwere G, Gsell PS, Longini IM, Riveros Balta X, Roberts CH, Marks M, Yao MNK, Gueye AS, Fall IS, Salama P, Ryan MJ, Henao-Restrepo AM; Ebola Ring Vaccination Team in the DRC. Muyembe JJ, et al. Among authors: roberts ch. N Engl J Med. 2024 Dec 19;391(24):2327-2336. doi: 10.1056/NEJMoa1904387. N Engl J Med. 2024. PMID: 39693543
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches).
Watson CH, Gsell PS, Hall Y, Camacho A, Riveros X, Enwere G, Vicari A, Nadlaou SD, Toure A, Sani IM, Diallo A, Kolie C, Duraffour S, Ifono K, Maomou A, Dore K, Djidonou HA, Bagayoko A, Damey PP, Camara MN, Diallo FB, Oumar FT, Toure K, Diaby ML, Sylla L, Conde D, Kaba IL, Tipton T, Eggo RM, Marks M, Roberts CH, Strecker T, Günther S, Keita S, Edmunds WJ, Carroll MW, Henao-Restrepo AM. Watson CH, et al. Among authors: roberts ch. BMC Med. 2024 Nov 7;22(1):523. doi: 10.1186/s12916-024-03726-z. BMC Med. 2024. PMID: 39511527 Free PMC article.
Predicting mortality in febrile adults: comparative performance of the MEWS, qSOFA, and UVA scores using prospectively collected data among patients in four health-care sites in sub-Saharan Africa and South-Eastern Asia.
Lal S, Luangraj M, Keddie SH, Ashley EA, Baerenbold O, Bassat Q, Bradley J, Crump JA, Feasey NA, Green EW, Kain KC, Olaru ID, Lalloo DG, Roberts CH, Mabey DCW, Moore CC, Hopkins H; Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE) Study Consortium. Lal S, et al. Among authors: roberts ch. EClinicalMedicine. 2024 Oct 4;77:102856. doi: 10.1016/j.eclinm.2024.102856. eCollection 2024 Nov. EClinicalMedicine. 2024. PMID: 39416389 Free PMC article.
Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo.
Choi EM, Kasonia K, Kavunga-Membo H, Mukadi-Bamuleka D, Soumah A, Mossoko Z, Edwards T, Tetsa-Tata D, Makarimi R, Toure O, Mambula G, Brindle H, Camacho A, Connor NE, Mukadi P, McLean C, Keshinro B, Gaddah A, Robinson C, Luhn K, Foster J, Roberts CH, Johnson JE, Imbault N, Bausch DG, Grais RF, Watson-Jones D, Muyembe-Tamfum JJ; Tujiokowe Study Consortium. Choi EM, et al. Among authors: roberts ch. Vaccines (Basel). 2024 Jul 23;12(8):828. doi: 10.3390/vaccines12080828. Vaccines (Basel). 2024. PMID: 39203955 Free PMC article.
130 results